• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Higher Mammographic Breast Density Consistently Associated With Increased DCIS Risk

by
November 14, 2026
in Cancer, Health
Reading Time: 2 mins read
0
Higher Mammographic Breast Density Consistently Associated With Increased DCIS Risk

Higher Mammographic Breast Density Consistently Associated With Increased DCIS Risk

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Higher mammographic breast density is consistently associated with an increased risk of ductal carcinoma in situ initiation across menopausal subgroups, according to a systematic review and meta-analysis published in Breast Cancer Research. Across eligible evaluations, higher mammographic density corresponded to a pooled relative effect of 2.36 (95% CI 1.79–3.11) for ductal carcinoma in situ (DCIS) development, with supporting investigations generally categorized as having a low risk of bias.

The systematic review and meta-analysis synthesized evidence from 35 eligible studies encompassing a total of 47,796 new diagnoses of ductal carcinoma in situ or diagnoses of ipsilateral invasive breast cancer. Researchers evaluated relationships linking breast density, metabolic risk factors, adipocyte-related measures, and background parenchymal enhancement with multiple DCIS outcomes across the identified clinical literature.

In evaluations of body mass index, investigators documented contrasting associations with ductal carcinoma in situ initiation depending on menopausal status. Higher body mass index was associated with a lower risk of DCIS initiation among premenopausal women, yielding a pooled relative effect of 0.74 (95% CI 0.63–0.87).

Conversely, among postmenopausal women, higher body mass index demonstrated an opposite directional pattern, but this observed association did not achieve statistical significance, showing a pooled relative effect of 1.17 (95% CI 0.99–1.37). These combined observations indicate that adiposity-related factors exhibit distinct patterns of association with early DCIS development across differing menopausal contexts.

The research team found that available evidence regarding other candidate biological markers was substantially more constrained. Specifically, studies addressing adipocyte-related measures, metabolic risk factors beyond body mass index, and recurrence outcomes following treatment were limited in volume and demonstrated marked heterogeneity.

Furthermore, the systematic review identified no eligible studies that evaluated disease progression to invasive breast cancer following untreated ductal carcinoma in situ. Ductal carcinoma in situ represents a non-obligate precursor of invasive breast cancer, yet factors associated with progression to invasive disease and recurrence of ipsilateral DCIS or invasive breast cancer remain poorly understood.

The authors noted that systemic and local microenvironment-related factors could potentially improve clinical risk stratification by distinguishing lesions that remain indolent from those possessing a high risk of progressing to invasive malignancy. However, while ductal carcinoma in situ initiation has been relatively well-described, the sparsity of evidence on progression and post-treatment recurrence highlights a critical ongoing research gap.

Subject of Research: Breast density and metabolic risk factors in ductal carcinoma in situ initiation and outcomes

Article Title: Breast density and metabolic factors in DCIS: systematic review and meta-analysis

Article References: Weiner, J. J., van den Heuvel, L. A., van der Mierden, S., DIRECT-DCIS Consortium, Schmidt, M. K., Bhattacharjee, P., Mann, R., Broeders, M. J. M., Verschuur, E., Retel, V., de Bekker-Grob, E., Bosman, P., Alderliesten, T., Verkooijen, H. M. L., Gernaat, S. A. M., Siesling, S., Bos, N. N., Wolkorte, R., van den Berg, M., … Wesseling, J. (2026). Breast density and metabolic factors in DCIS: systematic review and meta-analysis. Breast Cancer Research. https://doi.org/10.1186/s13058-026-02415-4

Image Credits: AI Generated

DOI: 10.1186/s13058-026-02415-4

Keywords: ductal carcinoma in situ, DCIS initiation, mammographic breast density, metabolic risk factors, body mass index, premenopausal women, postmenopausal women, ipsilateral invasive breast cancer, systematic review, meta-analysis, adipocyte-related measures, background parenchymal enhancement, risk stratification, indolent lesions, recurrence outcomes, local microenvironment

News Source: Nathaniel Bowman. (November 14, 2026). Higher Mammographic Breast Density Consistently Associated With Increased DCIS Risk. Scienmag.

Tags: adipocyte-related measuresbackground parenchymal enhancementbody-mass indexDCIS initiationductal carcinoma in situindolent lesionsipsilateral invasive breast cancerlocal microenvironmentmammographic breast densityMeta-analysismetabolic risk factorsPostmenopausal Womenpremenopausal womenrecurrence outcomesrisk stratificationsystematic review
Share12Tweet7Share2ShareShareShare1

Related Posts

Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for Gram-Negative Resistance

Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for Gram-Negative Resistance

November 20, 2026
Qualitative Study Identifies Drivers of HPV Vaccine Acceptance Ahead of Ghana Introduction

Qualitative Study Identifies Drivers of HPV Vaccine Acceptance Ahead of Ghana Introduction

November 20, 2026

Computational Study Links miR-130b-3p and NR3C2 Pairing to Kidney Cancer Outcomes

November 20, 2026

Rat Lungworm Infection Drives Divergent Gut Microbiome and Lipid Disruptions in Rodents

November 20, 2026

POPULAR NEWS

  • Chemical and Microbial Feedback Loops Drive Soil Sickness in Medicinal Crops

    Chemical and Microbial Feedback Loops Drive Soil Sickness in Medicinal Crops

    29 shares
    Share 12 Tweet 7
  • National Survey Reveals Significant Digital Gaps Among Groups Facing Oral Health Inequities

    29 shares
    Share 12 Tweet 7
  • Review Evaluates Strategies to Prevent and Treat Mandibular Nerve Injury During Jaw Surgery

    29 shares
    Share 12 Tweet 7
  • Dental Sector Dominates Japan’s Regional Outpatient Dysphagia Rehabilitation Claims

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for Gram-Negative Resistance

Qualitative Study Identifies Drivers of HPV Vaccine Acceptance Ahead of Ghana Introduction

Computational Study Links miR-130b-3p and NR3C2 Pairing to Kidney Cancer Outcomes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.